Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: A controlled, prospective study

Journal of Clinical Psychiatry

Volumn 57, Issue 12, 1996, Pages 582-587

  Wroblewski, Bruno A ^a,b,f   Joseph, Anthony B ^c,d,e   Cornblatt, Ronye R ^c  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b ASCO Healthcare   (United States)

^c Middlesex Hospital   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MCLEAN HOSPITAL   (United States)

^f Greenery Rehabilitation Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMANTADINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; BUSPIRONE; CARBAMAZEPINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; DESIPRAMINE; DEXAMPHETAMINE; DIAZEPAM; FLUOXETINE; LEVODOPA; METHYLPHENIDATE; NORTRIPTYLINE;

ADULT; AFFECT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MANIA; MOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEIZURE;

EID: 0030462833     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v57n1206     Document Type: Article

References (24)

1. Silver JM, Yudofsky SC, Hales RE. Depression in traumatic brain injury. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1991;4. 12-23
2. Fedoroff JP, Starkstein SE, Forrester AW, et al. Depression in patients with acute traumatic brain injury. Am J Psychiatry 1992;149:918-923
3. Van Zomeran AH, Van den Berg W. Residual complaints of patients two years after severe head injury. J Neurol Neurosurg Psychiatry 1985;48: 21-28
4. Jorge RE, Robinson RG, Arndt SV, et al. Depression following traumatic brain injury: a longitudinal study. J Affective Disord 1993;27:233-243
5. Gualtieri CT, Cox DR. The delayed neurobehavioral sequelae of traumatic brain injury. Brain Inj 1991;5:219-232
6. Levin HS, Grossman RG. Behavioral sequelae of closed head injury: a quantitative study. Arch Neurol 1978;35:720-727
7. Kinsella G, Moran C, Ford B, et al. Emotional disorder and its assessment within the severe head injured population. Psychol Med 1988;18:57-63
8. Saran AS. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants. J Clin Psychiatry 1985;46:335-338
9. Cassidy JW. Fluoxetine: a new serotinergically active antidepressant. Journal of Head Trauma Rehabilitation 1989;4:67-69
10. Divan TG, Mobayed M. Treatment resistance of depression after head injury: a preliminary study of amitriptyline response. Acta Psychiatr Scand 1992;85:292-294
11. Ross ED, Rush AJ. Diagnosis and neuroanatomical correlates of depression in brain-damaged patients. Arch Gen Psychiatry 1981;38.1344-1354
12. Robinson RG, Szetela B. Mood change following left hemispheric brain injury. Ann Neurol 1981;9:447-453
13. Jorge RE, Robinson RG, Arndt S. Are there symptoms that are specific for depressed mood in patients with traumatic brain injury? J Nerv Ment Dis 1993;181:91-99
14. Malkmus D, Booth DB, Kodimer C. Rehabilitation of the Head-Injured Adult: Comprehensive Cognitive Management. Downey, Calif: Professional Staff Association of Rancho Los Amigos Hospital; 1980
15. Ketter TA, Post RM, Worthington K. Principles of clinically important drug interactions with carbamazepine, part I. J Clin Psychopharmacol 1991;11:198-203
16. Lipsey JR. Robinson RG, Pearlson GD, et al. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984;1:297-300
17. Quitkin FM, Rabkin JG, Steward JW, et al. Heterogeneity of clinical response during placebo treatment. Am J Psychiatry 1991;148:193-196
18. Quitkin FM, McGrath PJ, Rabkin JG, et al. Different types of placebo response in patients receiving antidepressants. Am J Psychiatry 1991;148: 197-203
19. Wroblewski BS, McColgan K, Smith K, et al. The incidence of seizures during tricyclic antidepressant drug treatment in a brain injured population. J Clin Psychopharmacol 1990;10:124-128
20. Wroblewski BA, Guidos A, Leary J, et al. Control of depression with fluoxetine and antiseizure medication in a brain-injured patient [letter]. Am J Psychiatry 1992;149:273
21. Preskorn SH, Fast GA. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J Clin Psychiatry 1991;52(6, suppl):23-33;correction 1991;52:353
22. Levine R, Kenin M, Hoffman JS. Grand mal seizures associated with the use of fluoxetine. J Clin Psychopharmacol 1994;14:145-146
23. Boyeson MG. Neurochemical alterations after brain injury: clinical implications for pharmacologic rehabilitation. Neurorehabilitation 1991;1: 33-43
24. Boyeson MG, Harmon RL, Jones JL. Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. Am J Phys Med Rehabil 1994;73: 76-83